¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Persistent hyperplasia of thymus"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
¿µ¹® thymus(gland) ÇÑ±Û °¡½¿»ù
¼³¸í   
  °¡½¿ÀÇ ¾Õ À§ÂÊ¿¡ À§Ä¡ÇÑ ¸²ÇÁ¼º Àå±â·Î¼­, »çÃá±â¿¡ ÃÖ°íÀÇ ¹«°Ô¿¡ ´ÞÇß´Ù°¡ ÀÌÈÄ¿¡ ÅðÃàÇÑ´Ù. À̰ÍÀº ¼¼Æ÷¸Å°³ ¸é¿ª(cell-mediated immunity: ÁַΠT-¸²ÇÁ±¸¿¡ ÀÇÇØ ÀϾ¸ç, ÀÚ±â¿Í ´Ù¸¥ ¼¼Æ÷¿¡ ´ëÇÑ Àνİú À̽İźιÝÀÀ¿¡ °ü¿©ÇÔ)±â´ÉÀÇ ¹ß´Þ°ú ¼º¼÷¿¡ ÇÊ¿äÇÑ Àå±âÀ̸ç, È¸¹éÀû»öÀ¸·Î º¸Åë Á¤Á߸鿡¼­ °áÇÕÁ¶Á÷¿¡ ÀÇÇØ °áÇյȠµÎ °³ÀÇ ¿±À¸·Î µÇ¾î ÀÖ´Ù. °¡½¿»ùÀº »óÇǼ¼Æ÷, ¸²ÇÁ±¸, °¡½¿»ù¼¼Æ÷·Î ±¸¼ºµÇ¾î ÀÖÀ¸¸ç Àü±¸¼¼Æ÷°¡ °¡½¿»ù¿¡ ÀÌÇàÇÏ¿© ¸²ÇÁ±¸·Î ºÐÈ­µÇ°í, ±× ´ëºÎºÐÀº ÆÄ±«µÇ³ª ³ª¸ÓÁö´Â T¸²ÇÁ±¸¸¦ Çü¼ºÇÑ´Ù. °¡½¿»ùÀº ¶ÇÇѠȣ¸£¸ó À¯»ç¹°ÁúÀΠthymine, thymopoietin, thymosin µîÀ» ºÐºñÇÑ´Ù.
  
  
¿µ¹® persistent vegetative state ÇÑ±Û Áö¼Ó½Ä¹°»óÅÂ
¼³¸í   
  ±× ºÎÀ§¿¡ »ó°ü¾øÀÌ ³ú¼Õ»ó¿¡ ÀÇÇØ¼­ ÀϾ´Â °¢¼º»óÅ¿¡ À־ÀÇ ½ÉÇÑ ¹«¹ÝÀÀ»óÅ·μ­, ´ë³ú°ÑÁúÀÇ ±â´ÉÁ¤Áö, ¿ÜºÎȯ°æ¿¡ ´ëÇÑ ÀûÀýÇÑ ÀûÀÀ¹ÝÀÀÀÇ °á¿©, ¹«µ¿, ¹«¾ðÀ» Æ¯Â¡À¸·Î Çϸç, ³úÆÄ´Â Æòźȭ ¶Ç´Â ÀÌ»óȰµ¿À» ³ªÅ¸³½´Ù.
¿µ¹® hyperplasia ÇÑ±Û °ú´ÙÇü¼º, Áõ½Ä
¼³¸í   
  ±â´ÉÇ×ÁøÀ» À¯¹ß½Ã۴ ÀÚ±ØÀ» ¹Þ¾ÒÀ» ¶§ ºÐ¿­ÀÌ °¡´ÉÇÑ ¼¼Æ÷°¡ ¼¼Æ÷ºÐ¿­·Î ±× ¼ö°¡ Áõ°¡µÇ´Â °ÍÀ» Áõ½ÄÀ̶ó Çϸç, °á°úÀûÀ¸·Î ±× Á¶Á÷À̳ª Àå±âµµ Ä¿Áö°Ô µÈ´Ù. ºñ´ë´Â ´Ü¼øÈ÷ ¼¼Æ÷ÀÇ Áõ½ÄÀÌ ¾øÀÌ ¼¼Æ÷ÀÇ Å©±â°¡ Ä¿Áö´Â °æ¿ì¸¦ À̸£´Â ¸»ÀÌ´Ù.
¿µ¹® Benign Prostatic Hyperplasia(BPH) ÇÑ±Û Àü¸³»ùºñ´ë
¼³¸í   
  50¼¼ ÀÌ»óÀÇ ³²¼º¿¡ ºó¹ßÇϴ º´À¸·Î Àü¸³»ùÀÇ ¿äµµ ÁÖÀ§ ¿µ¿ª¿¡ Å«°áÀýÀ» Çü¼ºÇÏ¿©, À̰ÍÀÌ Ä¿Áö¸é ¿äµµ¸¦ ¾Ð¹ÚÇÏ¿© ºÎºÐÀû È¤Àº ¿ÏÀüÇÑ ¿äµµÆó»öÀ» ÀÏÀ¸Å°´Â º´ÀÌ´Ù. Áõ»óÀº ¿äµµÆó»ö¿¡ µû¸¥ ¼Òº¯ÀÇ °¨¼Ò¿Í ¹æ±¤ÀÚ±ØÁõ»óÀ¸·Î ºó´¢, ÀÜ´¢°¨, ¼Òº¯À» ÂüÀ» ¼ö ¾ø´Â Áõ»ó µîÀÌ´Ù. Ä¡·á´Â °æ¿äµµ Àü¸³»ù ÀûÃâ¼ú·Î Àü¸³¼±ÀÇ ºñ´ëÇÑ ºÎºÐÀ» ÀýÁ¦ÇؾߠÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • blood-thymus barrier
    Ç÷¾×°¡½¿»ùÀ庮, Ç÷¾×Èä¼±À庮
  • chronic persistent hepatitis
    ¸¸¼ºÁö¼Ó°£¿°
  • ostium primum persistent
    ù°±¸¸ÛÁö¼Ó(Áõ), ÀÏÂ÷°ø°³Á¸(Áõ)
  • persistent
    Áö¼Ó-, ÀÜ·ù-
  • persistent acantholytic dermatosis
    Áö¼Ó°¡½Ã¼¼Æ÷ÇØ¸®ÇǺκ´
  • persistent cathode ray tube
    Áö¼ÓÀ½±Ø¼±°ü
  • persistent cloaca
    ¹è¼³°­Á¸¼ÓÁõ
  • persistent fetal hemoglobin
    Áö¼ÓžÆÇ÷»ö¼Ò
  • persistent hyaloid artery
    ÀÜ·ùÀ¯¸®Ã¼µ¿¸Æ
  • persistent infection
    Áö¼Ó°¨¿°
  • persistent light reaction
    Áö¼Ó±¤¹ÝÀÀ
  • persistent palmoplantar pustulosis
    Áö¼Ó¼Õ¹ß¹Ù´Ú°í¸§¹°ÁýÁõ, Áö¼Ó¼Õ¹ß¹Ù´Ú³óÆ÷Áõ
  • persistent superficial dermatitis
    Áö¼ÓÇ¥ÀçÇǺο°
  • persistent tremor
    Áö¼Ó¶³¸²
  • persistent vegetative state
    Áö¼Ó½Ä¹°»óÅÂ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • persistent vegetative state
    Áö¼Ó½Ä¹°»óÅÂ
  • thymus
    °¡½¿»ù
  • hyperplasia
    °ú´ÙÇü¼º, Áõ½Ä(Áõ)
  • atypical adenomatous hyperplasia
    ºñÁ¤Çü»ùÁ¾Áõ½Ä
  • atypical complex hyperplasia
    ºñÁ¤Çüº¹ÇÕÀڱ󻸷Áõ½Ä
  • atypical cystic hyperplasia
    ºñÁ¤Çü³¶¼º½ÄÁõ
  • complex hyperplasia
    º¹ÇÕÁõ½ÄÁõ
  • congenital adrenal hyperplasia
    ¼±ÃµºÎ½Å°ú´ÙÇü¼º, ¼±ÃµÄáÆÏÀ§»ù°ú´ÙÇü¼º
  • intraductal hyperplasia
    °ü³»Áõ½Ä
  • lymphoid hyperplasia
    ¸²ÇÁ±¸Áõ½Ä
  • simple hyperplasia
    ´Ü¼øÁõ½ÄÁõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • thymus-dependent antigen
    °¡½¿»ùÀÇÁ¸Ç׿ø
  • thymus-dependent area
    °¡½¿»ùÀÇÁ¸±¸¿ª
  • thymus-independent antigen
    °¡½¿»ùºñÀÇÁ¸Ç׿ø
  • thymus-independent area
    °¡½¿»ùºñÀÇÁ¸±¸¿ª
  • blood-thymus barrier
    Ç÷¾×°¡½¿»ùÀ庮
  • thymus-dependent cell
    °¡½¿»ùÀÇÁ¸¼¼Æ÷
  • thymus-derived cell
    °¡½¿»ùÀ¯·¡¼¼Æ÷
  • thymus-independent cell
    °¡½¿»ùºñÀÇÁ¸¼¼Æ÷
  • thymus-derived lymphocyte
    °¡½¿»ùÀ¯·¡¸²ÇÁ±¸
  • thymus
    °¡½¿»ù
  • persistent hyaloid artery
    ÀÜ·ùÀ¯¸®Ã¼µ¿¸Æ
  • chronic persistent hepatitis
    ¸¸¼ºÁö¼Ó°£¿°
  • persistent cloaca
    ¹è¼³°­Á¸¼ÓÁõ
  • persistent acantholytic dermatosis
    Áö¼Ó°¡½Ã¼¼Æ÷ÇØ¸®ÇǺκ´
  • persistent superficial dermatitis
    Áö¼ÓÇ¥ÀçÇǺο°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • T cell ; T lymphocyte ; thymus derived lymphocyte
    T¼¼Æ÷ ; T¸²ÇÁ? ; Èä¼±À¯·¡¸²ÇÁ?
  • antigen, thymus-dependent
    Èä¼±ÀÇÁ¸Ç׿ø, °¡½¿»ùÀÇÁ¸Ç׿ø
  • antigen, thymus-independent
    Èä¼±ºñÀÇÁ¸Ç׿ø, °¡½¿»ùºñÀÇÁ¸Ç׿ø
  • antigen, thymus-leukemia
    Èä¼±-¹éÇ÷º´Ç׿ø, TLÇ׿ø
  • area, thymus-dependent
    Èä¼±ÀÇÁ¸¿ª, °¡½¿»ùÀÇÁ¸¿ª
  • Hyperplasia
    Áõ½Ä(ñòãÖ)
  • adrenal hyperplasia
    ºÎ½Å°úÇü¼º(¡­Î¦û¡à÷).
  • adrenal hyperplasia
    ºÎ½Å°úÇü¼º
  • adrenocorical hyperplasia
    ºÎ½ÅÇÇÁú °úÇü¼º
  • androgenic adrenal hyperplasia
    ³²¼ºÈ£¸£¸ó »ê¼º ºÎ½Å°úÇü¼º(Ñûàõ¡­ß§àõÜùãìΦû¡à÷).
  • angiolymphoid hyperplasia
    Ç÷¸²ÇÁ°üÁõ½Ä
  • angiolymphoid hyperplasia with eosinophilia
    È£»ê±¸Áõ°¡ Ç÷¸²ÇÁ°üÁõ½Ä
  • gingival hyperplasia
    Ä¡ÀºÁõ½Ä(Áõ)(öÍó»ñòãÖñø).
  • hyperplasia
    Áõ½Ä
  • hyperplasia
    °ú´ÙÇü¼º
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antigen, thymus-dependent
    Èä¼±ÀÇÁ¸Ç׿ø, °¡½¿»ùÀÇÁ¸Ç׿ø
  • antigen, thymus-independent
    Èä¼±ºñÀÇÁ¸Ç׿ø, °¡½¿»ùºñÀÇÁ¸Ç׿ø
  • antigen, thymus-leukemia
    Èä¼±-¹éÇ÷º´Ç׿ø, TLÇ׿ø
  • area, thymus-dependent
    Èä¼±ÀÇÁ¸¿ª, °¡½¿»ùÀÇÁ¸¿ª
  • blood thymus barrier
    Ç÷¾×°¡½¿»ùÀ庮, Ç÷Èä¼±À庮.
  • cell, thymus-dependent
    °¡½¿»ùÀÇÁ¸¼¼Æ÷, Èä¼±ÀÇÁ¸¼¼Æ÷
  • cell, thymus-derived
    °¡½¿»ùÀ¯·¡¼¼Æ÷, Èä¼±À¯·¡¼¼Æ÷
  • cortex of thymus
    °¡½¿»ù°ÑÁú
  • lobule of thymus
    °¡½¿»ù¼Ò¿±, Èä¼±(ýØàÍ)¼Ò¿±.
  • lobules of thymus
    °¡½¿»ù¼Ò¿±, Èä¼±(ýØàÍ)¼Ò¿±.
  • lobules of thymus
    °¡½¿»ù¼Ò¿±
  • medulla of thymus
    °¡½¿»ù¼ÓÁú
  • nodules of accessory thymus
    (µ¡°¡½¿»ù¼ÒÀý)
  • thymus
    Èä¼±, °¡½¿»ù
  • thymus
    Èä¼±(ýØàÍ)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Total hyperplasia (Macrodactylia)
    Àüü°ú´ÙÇü¼º (Å«¼Õ°¡¶ôÁõ)
    [¿¾ ¿ë¾î] ÀüüÀû°ÅÀÎÁõ
  • (Nodules of accessory thymus)
    (µ¡°¡½¿»ù¼ÒÀý)
    [¿¾ ¿ë¾î] ºÎÈä¼±¼ÒÀý
  • Medulla of thymus
    °¡½¿»ù¼ÓÁú
    [¿¾ ¿ë¾î] Èä¼±¼öÁú
  • Cortex of thymus
    °¡½¿»ù°ÑÁú
    [¿¾ ¿ë¾î] Èä¼±ÇÇÁú
  • Lobules of thymus
    °¡½¿»ù¼Ò¿±
    [¿¾ ¿ë¾î] Èä¼±¼Ò¿±
  • THYMUS
    °¡½¿»ù
    [¿¾ ¿ë¾î] Èä¼±
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • persistent induction
    Áö¼Ó À¯µµ(ò¥áÙë¯Óô)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • persistent thymus
    Á¸¼ÓÈä¼±
  • fibromuscular hyperplasia
    ¼¶À¯±Ù¼ºÁõ½ÄÁõ
  • hyperplasia
    °úÇü¼º, Áõ½Ä
  • persistent cathod ray tube
    Áö¼Ó¼ºÀ½±Ø¼±°ü
  • persistent primitive hypoglossal artery
    ¿ø½Ã¼³Çϵ¿¸Æ°³Á¸(Áõ)
  • T cell ¡ìthymus derived lymphocyte¡í
    T¼¼Æ÷ ¡ì Èä¼±À¯·¡ ¸²ÇÁ±¸¡í
  • thymus
    °¡½¿»ù, Èä¼±
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
TL temporal lobe; terminal limen; thermolabile; thermoluminescence; threat to life; thymus-leukemia [an...
PVS percussion, vibration, suction; persistent vegetative state; persistent viral syndrome; Plummer-Vins...
TP temperature and pressure; temperature probe; temporal peak; temporoparietal; tension pneumothorax; t...
TPF thymus permeability factor; thymus to peak flow; true positive fraction
MEN Multiple Endocrine Neoplasia
  ; AD Trait
  1. MEN Type I(= Wermer Syndro...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CT Calf thymus
CTL Cytotoxic thymus-derived lymphocytes
FTOC Fetal Thymus Organ Culture
FT fetal thymus
TL Thymus Leukemia
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • E32.0
    Persistent hyperplasia of thymus
    °¡½¿»ùÀÇ Áö¼ÓÀû Áõ½Ä
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • accessory thymus
    ºÎÈä¼±
    ¶§·Î´Â ¼±°ñÀÇ ³ôÀÌ¿¡¼­ º¼ ¼ö ÀÖ´Â Èä¼±ÀÇ ÀϺÎ. Èä¼±ÀÌ Çϰ­ÇÒ ¶§ ³²Àº °Í.
  • thymus
    °¡½¿»ù, Èä¼±
    1. È£¸£¸óÀ» ºÐºñÇÑ´Ù°í »ý°¢µÇ´Â ³»ºÐºñ¼±. 2. Á¾°Ýµ¿ÀÇ »óºÎ º¹Ãø¿¡ ÀÖ´Â ÀÙ ¸ð¾çÀÇ ¹èºÐºñ¼±À¸·Î À¯¾Æ±â¿¡ ÃÖ´ëÀÇ ¹ßÀ°À» ³ªÅ¸³»°í, ÁÂ¿ì ¾ç ¿±ÀÌ Á¤Áߺο¡¼­ À¯ÇÕÇÑ´Ù. ÇÇÁú°ú, ƯÀÌÀû ±¸Á¶ÀÎ Hassall ¼Òü¸¦ Æ÷ÇÔÇÏ´Â ¼öÁú·Î ÀÌ·ç¾îÁø´Ù.
  • thymus independent area
    Èä¼± µ¶¸³ºÎ, Èä¼± ºñÀÇÁ¸¿ª
    ºñÈä¼± ¸²ÇÁ±¸·Î ±¸¼ºµÈ ¸»ÃÊ ¸²ÇÁ ±â°üÀÇ ºÎºÐ.
  • thymus-dependent cell
    Èä¼± ÀÇÁ¸ ¼¼Æ÷
  • thymus-derived lymphocyte
    Èä¼± À¯·¡ Àӯı¸
  • persistent activity
    Áö¼ÓÀûÀΠȰ¼º
  • persistent generalized lymphadenopathy
    Áö¼ÓÀûÀÎ Àü½Å ¸²ÇÁÀýÁõ
  • persistent Müllerian duct syndrome
    ¹Á·¯°ü À¯Á¸ ÁõÈıº
    ¹Á·¯°ü ±¸Á¶, Áï ÀáÀç °íȯ, ¾çÃø¼º Á¤·ù °íȯ, ¾çÃø¼º Àڱðú, ÀÚ±Ã, »óºÎÁúÀÇ Áö¼ÓÀû ÀÜÁ¸ »óŸ¦ ³ªÅ¸³»´Â Áúȯ. ÀÏÃø¼º ÀáÀç °íȯ ¹× ¹Ý´ëÃø ¼­ÇýºÎ Å»ÀåÀÌ µ¿¹ÝµÇ±âµµ ÇÏ´Â À¯Àü¼º ÁúȯÀÌ´Ù.
  • persistent painful disc derangement
    Áö¼ÓÀûÀÎ µ¿Å뼺 °üÀý¿øÆÇ ³»Àå
  • persistent primitive hypoglossal artery
    ¿ø½Ã ¼³ÇÏ µ¿¸Æ °³Á¸, ¿ø½Ã ¼³ÇÏ µ¿¸Æ °³Á¸Áõ
  • persistent truncus arteriosus
    µ¿¸Æ°£ ÀÜÁ¸
  • persistent vegetative state
    Áö¼ÓÀû ½Ä¹° »óÅÂ
  • venae cava superior, persistent left
    Á¸¼Ó¼º Á»ó ´ëÁ¤¸Æ
    Á»ó ´ëÁ¤¸ÆÀÌ »ýÈÄ¿¡µµ Á¸¼ÓÇÏ´Â ¹ß»ýÇÐÀû ±âÇüÀ¸·Î¼­ º¸Åë Á½ɹ濡 Ç÷¾×À» ºñ¿î´Ù. ÁÂÀüÁÖ Á¤¸Æ »óºÎÀÇ Æó¼â Àå¾Ö¿¡ ÀÇÇÑ´Ù. ´Üµ¶¼º ±âÇüÀÇ °æ¿ìµµ ÀÖ°í Follot 4¡ÈÄ¿Í °°Àº ´Ù¸¥ ½ÉÇ÷°ü Àå¾Ö¸¦ ¼ö¹ÝÇÏ´Â °æ¿ìµµ ÀÖ´Ù.
  • adrenal hyperplasia
    ºÎ½Å °úÇü¼º
  • adrenocorical hyperplasia
    ºÎ½Å ÇÇÁú °úÇü¼º
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
thymus hyperplasia Enlargement of the thymus. A condition described in the late 1940's and 1950's as pathological thymic hypertrophy was status thymolymphaticus and was treated with radiotherapy. Unnecessary removal of the thymus was also practiced. It later became apparent that the thymus undergoes normal physiological hypertrophy, reaching a maximum at puberty and involuting thereafter. The concept of status thymolymphaticus has been abandoned. Thymus hyperplasia is present in two thirds of all patients with myasthenia gravis.
(12 Dec 1998)
ribonuclease h, calf thymus <enzyme> A ribonuclease that specifically cleaves the RNA moiety of RNA:DNA hybrids. It has been isolated from a wide variety of prokaryotic and eukaryotic organisms (particularly calf thymus) as well as retroviruses.
Registry number: EC 3.1.26.4
(12 Dec 1998)
persistent Continuing to exist in spite of interference or treatment, tending to recur.
(18 Nov 1997)
persistent anterior hyperplastic primary vitreous A unilateral congenital abnormality occurring in full-term infants; characterised by a retrolental fibrovascular membrane formed by persistent primary vitreous with remnants of the hyaloid artery and tunica vasculosa lentis; associated with leukokoria, microphthalmos, shallow anterior chamber, and elongated ciliary processes.
(05 Mar 2000)
persistent atrioventricular canal A condition that is caused when the atrial and ventricular septa fail to meet, as in normal development, resulting in a low atrial and high ventricular septal defect or a common atrioventricular canal.
Synonym: endocardial cushion defect.
(05 Mar 2000)
persistent chronic hepatitis A benign chronic hepatitis that may follow acute viral hepatitis A or B, or complicate bowel diseases; after six months, liver biopsy changes are mild, unlike active chronic hepatitis; rarely, if ever, progresses to cirrhosis, portal hypertension, or liver failure.
(05 Mar 2000)
persistent cloaca A condition in which the urorectal fold has failed to divide the cloaca of the embryo into rectal and urogenital portions.
Synonym: sinus urogenitalis, urogenital sinus.
(05 Mar 2000)
persistent ectopic pregnancy An ectopic pregnancy which has persistent viable tissue, secreting hCG after conservative surgery.
(05 Mar 2000)
persistent foetal circulation syndrome <syndrome> A syndrome of persistent pulmonary hypertension in the newborn infant, without demonstrable cardiac disease. It is characterised by cyanosis and acidosis, severe pulmonary vasoconstriction, hypertrophy of pulmonary arterial muscle, and elevated pulmonary vascular resistance, with resultant right-to-left shunting of blood through a patent ductus arteriosus and at times a patent foramen ovale.
(12 Dec 1998)
persistent generalised lymphadenopathy A syndrome characterised by reactive hyperplasia of lymph nodes (of at least one month's duration and at two different body sites, not including the inguinal area) in patients infected with the human immunodeficiency virus. The lymph node lesions progress from benign reactive hyperplasia through a stage of mixed follicular hyperplasia, to follicular involution with lymphocyte depletion. Many go on to a malignant non-Hodgkin's lymphoma.
(05 Mar 2000)
persistent mullerian duct syndrome <syndrome> Familial disorder with presence of fallopian tube, uterus, and testis in a male. Deficient mullerian inhibitory substance secondary to Sertoli cell defect.
Synonym: hernia uteri inguinale.
(05 Mar 2000)
persistent posterior hyperplastic primary vitreous A unilateral congenital anomaly in full-term infants; associated with a congenital retinal fold and a vitreous membranous stalk containing remnants of the hyaloid artery.
(05 Mar 2000)
persistent tremor A tremor that is constant, whether the subject is at rest or moving.
Synonym: continuous tremor.
(05 Mar 2000)
persistent truncus arteriosus A congenital cardiovascular deformity resulting from failure of development of the spiral septum and consisting of a common arterial trunk opening out of both ventricles, the pulmonary arteries being given off from the ascending common trunk.
(05 Mar 2000)
persistent vegetative state A persistent loss of upper cortical function that may follow acute (e.g., infections, toxins, trauma or vascular) events or chronic (e.g., degenerative) events. The patient is bedridden and nutritional support is completely passive, either parenteral or via nasogastric tube. The patient does not require respiratory support or circulatory assistance for survival and is in a state of chronic wakefulness without awareness which may be accompanied by spontaneous eye opening, grunts or screams, brief smiles, sporadic movement of facial muscles and limbs. While the eyes blink upon stimulation, they do not do so in response to visual threats. Some patients chew or clamp their teeth. Urinary and faecal incontinence is universal.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • thymus
    Èä¼±(ÀÇ)
  • persistent
    °íÁýÇÏ´Â; Áý¿äÇÑ; ²÷ÀÓ¾ø´Â
  • persistent
    °íÁýÇÏ´Â;ºÒ±¼ÀÇ;Áö¼ÓÇÏ´Â;°íÁý;Áö¼Ó
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á